Society of Urodynamics, Female Pelvic
Medicine & Urogenital Reconstruction
Find a Member
Conflict of Interest Policy
Travel & Transportation
Needs & Objectives
COVID-19 Relief Tool Kits
NAU iOS App
Care Pathways – OAB CCP
Mesh Midurethral Slings
Billing and Coding
Telemedicine During COVID-19 Pandemic
Lifetime Achievement Award
Distinguished Service Award
Continence Care Champion Award
Clinical Essay Award
Basic Science Essay Award
Basic Science Podium Award
Basic Science Poster Award
Resident Travel Awards
Neuromodulation Research Grant Winners
Chemodenervation Grant Winners
OAB Fecal Incontinence Grant Winners
OAB Urgency Urinary Incontinence Grant Winners
What is FPMRS
Fellowship Updates & Announcements
CALL FOR ABSTRACT SUBMISSIONS FOR THE 2021 WINTER MEETING
read more »
Registration Now Open!
Join us Feburary 23 - 27 for the 2021 Winter Meeting at the Grand Hyatt Nashville!
read more »
Congratulations to Our 2020 Award Winners
(l-r) Immediate Past President Kathleen Kobashi; Lifetime Achievement Award winner Victor Nitti; Paul Zimskind Award winner Anne Suskind; Distinguished Service Award winner Roger Dmochowski; and President Sandip Vasavada
read more »
SUFU Statement Regarding FDA Communication on “Vaginal Rejuvenation”
read more »
Announcing the SUFU Visiting Professorship
This 1-day visiting professorship will be offered to interested training programs and will consist of a lecture series from a member of the SUFU Executive Committee encompassing all aspects of FPMRS, Urodynamics, and Neurourology.
read more »
Overactive Bladder Clinical (OAB) Care Pathway
SUFU is providing the Overactive Bladder Clinical Care Pathway for use by providers and patients.
Overactive Bladder CCP Provider Flowchart »
Overactive Bladder CCP Patient Roadmap »
read more »
Updates & Announcements
NAU Online Journal
Donate to the
SUFU Research Foundation
News & Announcements
SUFU’s Response to Recent Violence & Health Disparities
In the past three months, we have experienced extraordinary challenges and we have witnessed communities of color and the economically disadvantaged disproportionately dying from COVID-19....
2020 SUFU Resident Preceptorship Canceled
The 2020 SUFU Resident Preceptorship sponsored by the SUFU Foundation has been canceled this year due to the COVID-19 health crisis. We look forward to seeing you next year. Please check back in April 2021 for further details....
Neurourology and Urodynamics
Cognitive challenges in persons with spina bifida: Bearing on urological dysfunctions?
Tuesday, September 22, 2020
Abstract Aim To evaluate if adult persons with spina bifida (SB) who have urinary tract complications have cognitive difficulties that can be identified by neuropsychological tests. Methods All individuals with SB ≥ 18 years of age registered at a regional outpatient clinic (n = 219) were invited, of which, 154 persons were included. Neuropsychological assessment of their cognitive status was performed with Wechsler Adult Intelligence Scale®—Fourth Edition: Coding, Block design, Arithmetic's, FAS (word generation), Rey Auditory Verbal Test for learning, and delayed recall 30 min. Bladder and bowel function were assessed with questions used by the Nordic Spinal Cord Injury Registry (NSCIR) in structured interviews, by questionnaires, and by chart reviews. Results Average neuropsychological test results for this SB population was shown to be approximately 1 SD under the median for the general population. The Coding test showed significantly lower test results as compared with the whole SB group in persons with urinary tract complications, especially urinary tract infections, reduced kidney function, dependent emptying of the bladder, and the bowel and accidental bowel leakage. The Arithmetic's test showed a significant difference between subgroups in all parameters except reduced kidney function whereas the other neuropsychological tests were significantly correlated with some but not all urological parameters. Conclusion We propose neuropsychological testing with primarily two tests to find those persons with SB who, due to cognitive challenges, might need extra support to minimize urological complications.
Alkalinized lidocaine solution as a first‐line local anesthesia protocol for intradetrusor injection of onabotulinum toxin A: Results from a double‐blinded randomized controll...
Monday, September 21, 2020
Abstract Aims Local anesthesia protocols for intradetrusor onabotulinum toxin A (BoNTA) injection lack standardization. We aimed to determine if an alkalinized lidocaine solution is more effective than lidocaine only. Methods Patients of both genders aged 18 or above enlisted for intradetrusor BoNTA injection (idiopathic, neurogenic, and bladder pain syndrome) were included in a double‐blinded randomized controlled trial after obtaining their informed consent. All participants filled a bladder diary and a urine culture was performed. Subjects were randomized 1:1 to Protocol A (20 ml 2% lidocaine + 10 ml 8.4% sodium bicarbonate) or Protocol B (20 ml 2% lidocaine + 10 ml 0.9% saline solution). A Numeric Rating Scale (0–10) was used to assess the level of pain immediately after the procedure (primary endpoint). Secondary endpoints included pain after 1 h, urinary tract infection, acute urinary retention, and hematuria related to the procedure. Results A total of 116 patients were randomized. Baseline characteristics (age, sex, indication, and bladder diary parameters) of patients in Group A and B were similar. Pain scores at the end of the procedure were significantly lower with the alkalinized solution (Protocol A and B, respectively, 2.37 ± 0.31 vs. 4.44 ± 0.36, p < .01). No differences were observed 1 h after treatment (Protocol A and B, respectively, 0.54 ± 0.17 vs. 0.69 ± 0.19, p = .487). The only adverse event reported was mild‐to‐moderate self‐limited hematuria in 15.4% of patients. Conclusions The use of an alkalinized lidocaine solution has proven to be significantly superior to lidocaine only as local anesthesia before intradetrusor BoNTA injection, suggesting that this may be considered a first‐line option.
Find a Urologist